Current techniques in wound healing modulation in glaucoma surgery

Current Opinion in Ophthalmology

Volumn 7, Issue 2, 1996, Pages 24-33

  Khaw, Peng T ^a   Migdal, C S ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

CATARACT EXTRACTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA DISEASE; DRAIN; GLAUCOMA SURGERY; HIGH RISK POPULATION; HUMAN; INTRAOCULAR PRESSURE; MUSCLE HYPOTONIA; NEOVASCULAR GLAUCOMA; PRIORITY JOURNAL; REVIEW; SCAR FORMATION; SUBCONJUNCTIVAL DRUG ADMINISTRATION; SUTURING METHOD; TRABECULECTOMY; WOUND HEALING;

EID: 0029737440     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-199604000-00005     Document Type: Review

References (56)

1. Sommer A: Intraocular pressure and glaucoma [editorial]. Am J Ophthalmol 1989, 107:186-188.
2. Gressel MG, Parrish RK III, Folberg R: 5-Fluorouracil in glaucoma filtration surgery: I. An animal model. Ophthalmology 1984, 91:378-383.
3. Heuer DK, Parrish RK III, Gressel MG: 5-Fluorouracil in glaucoma filtering surgery: H. A pilot study. Ophthalmology 1984, 91:384-394.
4. Khaw PT, Sherwood MB, MacKay SLD, Rossi MJ, Schultz GS: Five-minute treatments with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon's capsule fibroblasts. Arch Ophthalmol 1992, 110:1150-1154.
5. Jampel HD: Effect of brief exposure to mitomycin C on viability and proliferation of cultured human Tenon's capsule fibroblasts. Ophthalmology 1992, 99:1471-1476.
6. Chen CW: Enhanced intraocular pressure controlling effectiveness of trabeculectomy by local application of mitomycin C. Trans Asia Pacif Acad Ophthal 1983, 91:172-177.
7. Khaw PT, Occleston NL, Schultz GS, Grierson I, Sherwood MB, Larkin G: Activation and suppression of fibroblast activity. Eye 1994, 8:188-195.
8. Kitazawa Y, Kawase K, Matsushita H, Minobe M: Trabeculectomy with mitomycin: a comparative study with fluorouracil. Arch Ophthalmol 1991, 109:1693-1698.
9. Katz GJ, Higginbotham EJ, Lichter PR, Skuta GL, Musch DC, Bergstrom •• TJ, Johnson AT: Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology 1995, 102:1263-1269. Medium-term follow-up of a randomized prospective trial comparing 5-fluorouracil injections and intraoperative mitomycin C in high-risk patients. There was better IOP control with mitomycin C.
10. Lamping KA, Belkin JK: 5-Fluorouracil and mitomycin C in pseudopha•• kic patients. Ophthalmology 1995, 102:70-75. A randomized, prospective study of 5-fluorouracil injections versus intraoperative mitomycin C in pseudophakic patients. Mitomycin C provided better IOP control.
11. Prata JA, Minckler DS, Baerveldt G, Lee PP, LaBree L, Heuer DK: Trabeculectomy in pseudophakic patients: postoperative 5-fluorouracil versus intraoperative mitomycin C antiproliferative therapy. Ophthalmic Surg 1995, 26:73-77.
12. Tsai JC, Feuer WJ, Parrish RK, Grajewski AL: 5-Fluorouracil filtering • surgery and neovascular glaucoma. Ophthalmology 1995, 102:887-888. Long-term filtration surgery failure even combined with 5-fluorouracil injections continues to occur in this aggressive condition.
13. Whiteside-Michel J, Liebmann JM, Ritch R: Initial 5-fluorouracil trabeculectomy in young patients. Ophthalmology 1992, 99:7-13.
14. Wilson RP, Steinman WC: Use of trabeculectomy with postoperative 5-fluorouracil in patients requiring extremely low intraocular pressure levels to limit further glaucoma progression. Ophthalmology 1991, 98:1047-1052.
15. Kupin TH, Juzych MS, Shin DH, Khatana AK, Olivier MMG: Adjunctive mitomycin C in primary trabeculectomy in phakic eyes. Am J Ophthalmol 1995, 119:30-39.
16. Stamper RL, McMenemy MG, Lieberman MF. Hypotonous maculopathy after trabeculectomy with subconjunctival 5FU. Am J. Ophthalmol 1992, 114:544-553.
17. Broadway DC, Grierson I, O'Brien C, Hitchings RA: Adverse effects of •• topical antiglaucoma medication. Arch Ophthalmol 1994, 112:1446-1454. Topical medications, especially adrenaline, appear to compromise the success of glaucoma filtration surgery significantly.
18. Broadway DC, Grierson I, Hitching RA: Reversal of topical antiglaucoma medication effects on the conjunctiva. Arch Ophthalmol 1996, 114:262-267.
19. Gwynn DR, Stewart WC, Pitts RA, McMillian TA, Hennis HL: Conjunctival structure and cell counts and the results of filtering surgery. Am J Ophthalmol 1993, 116:464-468.
20. Goldenfeld M, Krupin T, Ruderman JM, Wong PC, Rosenberg LF, Ritch R, • Liebmann JM, Giesser DK: 5-Fluorouracil in initial trabeculectomy: a prospective randomized, multicenter study. Ophthalmology 1994, 101:1024-1029. This prospective, randomized, multicenter study showed that the use of 5-fluorouracil injections resulted in lower IOPs in the longer term.
21. Khaw PT, Doyle JW, Sherwood MB, Grierson I, Schultz GS, McGorray S: Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin C. Arch Ophthalmol 1993, 111:263-267.
22. Doyle JW, Sherwood MB, Khaw PT, McGorray S, Smith MF: Intraoperative 5-fluorouracil for filtration surgery in the rabbit. Invest Ophthalmol Vis Sci 1993, 34:3313-3319.
23. Lanigan LP, Stuermer J, Baez KA, Hitchings RA, Khaw PT: Single intraoperative applications of 5-fluorouracil during filtration surgery: early results. Br J Ophthalmol 1994, 78:33-37.
24. Feldman RM, Dietze PJ, Gross RL, Oram O: Intraoperative 5-fluorouracil administration in trabeculectomy. J Glaucoma 1994, 3:302-307.
25. Egbert PR, Williams AS, Singh K, Dadzie P, Egbert TB: A prospective trial of intraoperative fluorouracil during trabeculectomy in a black population. Am J Ophthalmol 1993, 116:612-616.
26. Khaw PT, Doyle JW, Sherwood MB, Smith FM, McGorray S: Effects of intraoperative 5-fluorouracil or mitomycin C on glaucoma filtration surgery in the rabbit. Ophthalmology 1993, 110:367-372.
27. Shin DH, Simone PA, Song MS, Reed SY, Juzych MS, Kim C, Hughes BA: •• Adjunctive subconjunctival mitomycin C in glaucoma triple procedure. Ophthalmology 1995, 102:1550-1558. This prospective, randomized study showed no significant difference in IOP in patients who received either no adjunctive treatment or intraoperative mitomycin C during primary trabeculectomy combined with phacoemulsification.
28. Munden PM, Alward WLM: Combined phacoemulsification, posterior chamber intraocular lens implantation and trabeculectomy with mitomycin C. Am J Ophthalmol 1995, 119:20-29.
29. Joos KM, Bueche MJ, Palmberg PF, Feuer WJ, Grajewski AL: One-year follow-up results of combined mitomycin C trabeculectomy and extra-capsular cataract extraction. Ophthalmology 1995, 102:76-83.
30. Susanna R, Nicolela MT, Takahashi WY: Mitomycin C as adjunctive therapy with glaucoma implant surgery. Ophthalmic Surg 1994, 25:458-462.
31. Perkins TW, Cardakli F, Eisele JR, Kaufman PL, Heatley GA: Adjunctive mitomycin C in Molteno implant surgery. Ophthalmology 1995, 102:91-97.
32. Mietz H, Addicks K, Krieglstein GK: A scleral shield for the application of mitomycin C during trabeculectomy: a rabbit model. Ophthalmic Surg 1994, 25:446-470.
33. Chen C, Huang H, Bair JS, Lee C: Trabeculectomy with simultaneous topical application of mitomycin C in refractory glaucoma. J Ocul Pharmacol 1990, 6:175-182.
34. Kitazawa Y, Suemori-Matsushita H, Yamomoto T, Kawase K, Low-dose and high-dose mitomycin trabeculectomy as an initial surgery in primary open-angle glaucoma. Ophthalmology 1993, 100:1624-1628.
35. Megevand GS, Salmon JF, Scholtz RP, Murray ADN: The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery. Ophthalmology 1995, 102:84-90.
36. Neclakantan A, Rao BS, Vijaya L, et al.: Effect of the concentration and duration of application of mitomycin C in trabeculectomy. Ophthalmic Surg 1994, 25:612-615.
37. Wohlheuter RM, Mclvor RS, Plagemann PGW: Facilitated transport of uracil and 5-fluorouracil, and permeation of orotic acid into cultured mammalian cells. J Cell Physiol 1980, 104:209-219.
38. Flynn WJ, Carlson DW, Bifano SL: Mitomycin trabeculectomy: the mi• crosurgical sponge difference. J Glaucoma 1995, 4:86-90. The amount of mitomycin C may vary a great deal depending on the sponge used.
39. Shin DH, Reed SY, Swords RC, Reed AH, Simone PA, Birt CM: Cellulose sponge punch for controlled mitomycin application. Arch Ophthalmol 1994, 112:1624-1626.
40. Mietz H, Addicks K, Diestelhorst M, Krieglstein G: Extraocular application of mitomycin C in a rabbit model: cytotoxic effects on the ciliary body and epithelium. Ophthalmic Surg 1994, 25:240-244.
41. Hollo G, Suveges I: The effect of brief intrascleral or opiscleral application of mitomycin C on the ciliary epithelium and pressure in the rabbit eye. Acta Ophthalmol (Copenh) 1994, 72:739-742.
42. Scah SKL, Prata JA, Minckler DS, et al: Mitomycin-C concentration in human aqueous humour following trabeculectomy. Eye 1993, 7:652-655.
43. Khaw PT, Tsai J, Constable P, Cordeiro F, Occleston N: Preventing scarring after glaucoma filtration surgery with single application agents: a practical approach. Asia-Pac J Ophthalmol 1995, 6:35-42.
44. Wolner B, Liebmann JM, Sassani JW, Ritch R, Speaker M, Marmor M: Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil. Ophthalmology. 1991, 98:1053-1060.
45. Fourman S: Scleritis after glaucoma filtering surgery with mitomycin C. Ophthalmology 1995, 102:1569-1571.
46. Smith MF, Sherwood MB, Doyle JW, Khaw PT: Results of intraoperative 5-fluorouracil supplementation on trabeculectomy for open-angle glaucoma. Am J Ophthalmol 1992, 114:737-741.
47. The Fluorouracil Filtering Surgery Study Group: Fluorouracil filtering surgery study one-year follow-up. Am J Ophthalmol 1989, 108:625-635.
48. Weinreb RN: Adjusting the dose of 5-fluorouracil after filtration surgery to minimize side effects. Ophthalmology 1987, 94:564-570.
49. Khaw PT, Ward S, Porter A, Grierson I, Hitchings RA, Rice NSC: The long-term effects of 5-fluorouracil and sodium butyrate on human Tenon's fibroblasts. Invest Ophthalmol Vis Sci 1992, 33:2043-2052.
50. Traverso CE, Facino M, Murialdo U, Corazza M, Gandolfo E, Calabria G: Decreased corneal complications after no-reflux, low dose 5-fluorouracil subconjunctival injection following trabeculectomy. Int Ophthalmol 1995, 18:247-250.
51. Gandolfi SA, Vecchi M, Braccio L: Decrease of intraocular pressure after subconjunctival injection of mitomycin in human glaucoma. Arch Ophthalmol 1995, 113:582-585.
52. Nuyts RMMA, Van Diemen HAM, Greve EL: Occlusion of the retinal vasculature after trabeculectomy with mitomycin C. Ophthalmol 1994, 18:167-170. Severe complications following subconjunctival injection of mitomycin C.
53. . Smith MF, Magauran RG, Betchkal J, Doyle JW. Treatment of postfiltra• tion bleb leaks with autologous blood. Ophthalmology 1995, 102:868-871. The authors used peribleb rather than intrableb blood to treat hypotonous or leaking blebs after mitomycin C. This technique theoretically reduces the risk of intraocular entry of blood and postinjection pressure spikes.
54. Wise JB: Treatment of chronic postfiltration hypotony by intrableb injection of autologous blood. Arch Ophthalmol 1993, 111:827-830.
55. Alward WLM: Marked intraocular pressure rise following blood injec• tion into the filtering bleb. Arch Ophthalmol 1995, 113:1232-1233. Marked pressure rise (to 60 mm Hg) only relieved by paracentesis when blood injection combined with anterior chamber viscoelastic. The author no longer uses viscoelastic agents when carrying out intrableb blood injections. We would agree.
56. Duker JS, Schuman JS: Successful surgical treatment of hypotony maculopathy following trabeculectomy with topical mitomycin C. Ophthalmic Surg 1994, 25:463-465.